Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$7.4 - $11.66 $6,216 - $9,794
-840 Closed
0 $0
Q4 2020

Jan 20, 2021

BUY
$5.98 - $12.47 $5,023 - $10,474
840 New
840 $7,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $744M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Johnson Midwest Financial, LLC Portfolio

Follow Johnson Midwest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Midwest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Midwest Financial, LLC with notifications on news.